Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin

Sarah J Petit1, Caroline Blondeau1, Greg J Towers1

  • 1MRC Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, Cruciform Building, 90 Gower Street, London WC1E 6BT, UK.

Insights

Human immunodeficiency virus type-1 (HIV) O group Vpu proteins cannot antagonize tetherin, potentially explaining their limited human-to-human transmission. This study reveals key Vpu domains for tetherin interaction and HIV pandemic spread.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Human immunodeficiency virus type-1 (HIV) originated from simian immunodeficiency virus (SIVcpz) in chimpanzees, leading to pandemic (HIV-1 group M) and non-pandemic (groups O, N, P) strains.
  • The accessory protein Vpu is crucial for HIV replication, mediating CD4 downregulation and virion release by antagonizing tetherin (BST2).

Purpose of the Study:

  • To investigate why HIV-1 group O Vpu proteins are less effective at antagonizing tetherin compared to group M.
  • To identify the molecular mechanisms underlying Vpu's interaction with tetherin and its role in HIV pandemic potential.

Main Methods:

  • Comparative analysis of Vpu proteins from HIV-1 group O and group M viruses.
  • Construction and characterization of chimeric Vpu proteins and Vpu mutants.
  • Assessment of Vpu's ability to counteract tetherin, downregulate cell-surface CD4, and promote virion release.
  • Investigation of Vpu's cellular localization, particularly its interaction with the trans-Golgi network.

Main Results:

  • HIV-1 group O Vpu proteins (Ca9, BCF06) failed to antagonize tetherin or downregulate it from the cell surface, despite reducing cell-surface CD4 levels.
  • Chimeric Vpu proteins and mutants revealed that specific residues in the transmembrane proximal region and the transmembrane domain are critical for tetherin antagonism and enhanced virion release.
  • Group M Vpu localization to the trans-Golgi network is essential for tetherin relocalization and antagonism.

Conclusions:

  • The inability of group O Vpu to antagonize tetherin is a significant factor limiting the pandemic potential of these viruses.
  • The Vpu-tetherin interaction is complex, involving specific molecular domains and cellular localization, which are key determinants of HIV pandemic spread.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...